Theorem Clinical Research

United States

Crohn's & Colitis Foundation of America, ResearchMatch partner

Wednesday, January 14, 2015 12:32 PM

ResearchMatch, a U.S.-wide, disease-neutral, volunteer research recruitment and engagement platform, is partnering with the Crohn's & Colitis Foundation of America (CCFA), a volunteer-driven organization dedicated to curing Crohn's disease and ulcerative colitis, and improving the quality of life of children and adults affected by those diseases.

More... »

Quest Diagnostics

goBalto releases latest update of goBalto Activate

Wednesday, January 14, 2015 12:32 PM

goBalto, a San Francisco, Calif.-based provider of cloud-based clinical study startup solutions, has released its latest version of goBalto Activate, its flagship study startup platform.

More... »


Novella Clinical, Cardiovascular Research Foundation collaborate, provide clinical trial expertise

Monday, January 12, 2015 02:37 PM

Novella Clinical, a Quintiles company, and the Cardiovascular Research Foundation (CRF), an independent, academically focused nonprofit organization based in New York, have announced a preferred provider collaboration that will offer a set of clinical trial services to developers of cardiovascular drugs and devices.

More... »

MedNet Solutions updates iMedNet eClinical

Friday, January 9, 2015 02:03 PM

MedNet Solutions, a Minnetonka, Minn.-based global life sciences technology company specializing in clinical study management systems, has updated iMedNet eClinical, its innovative, cloud-based technology platform. iMedNet said its software-as-a-service (SaaS) solution is intuitive, flexible and affordable for sponsors and CROs wishing to quickly and efficiently build studies themselves.

More... »

Inovio Pharmaceuticals HIV immunotherapy shows vital characteristics

Thursday, January 8, 2015 02:28 PM

Inovio Pharmaceuticals has reported results from a 12-patient, phase I study of Inovio's HIV immunotherapy, PENNVAX-B, in HIV-infected patients revealed that immune response characteristics generated by the immunotherapy were similar to those observed in HIV-infected individuals who without treatment do not progress to further stages of the disease.

More... »

FDA grants Soligenix Fast Track designation for SGX301 for lymphoma

Thursday, January 8, 2015 02:12 PM

Soligenix, a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, has announced that its SGX301 (synthetic hypericin) development program for the first-line treatment of cutaneous T-cell lymphoma (CTCL) has received Fast Track designation from the FDA.

More... »

American Diabetes Association announces new national officers and board members

Thursday, January 8, 2015 01:54 PM

The American Diabetes Association, a voluntary health organization leading the fight to Stop Diabetes, has announced its officers and board of directors members for 2015.

More... »

Carl Feldbaum joins Trovagene's board of directors

Thursday, January 8, 2015 01:17 PM

Trovagene, a developer of cell-free molecular diagnostics, has announced that Carl Feldbaum, president emeritus of the Biotechnology Industry Organization (BIO), a biotechnology trade association, has been appointed to its board of directors. He also will be chairman of the company's Corporate Governance and Nominating committee.

More... »

Iodine launches cold and flu app to help consumers find best OTC options for their symptoms

Monday, December 22, 2014 02:06 PM

San Francisco-based Iodine, developer of health information web site Iodine.com, has launched a new web app for cold and flu season.

More... »

14 indicted in connection with 2012 nationwide fungal meningitis outbreak

Friday, December 19, 2014 02:29 PM

The Justice Department unsealed a 131-count criminal indictment in Boston in connection with the 2012 nationwide fungal meningitis outbreak. Barry J. Cadden, owner and head pharmacist of New England Compounding Center (NECC), and NECC’s supervisory pharmacist Glenn A. Chin were charged with 25 acts of second-degree murder in Florida, Indiana, Maryland, Michigan, North Carolina, Tennessee and Virginia.   

More... »

`

CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs